ASXL3 gene mutations inhibit cell proliferation and promote cell apoptosis in mouse cardiomyocytes by upregulating lncRNA NONMMUT063967.2

van der Linde, 2011, Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis, J. Am. Coll. Cardiol., 58, 2241, 10.1016/j.jacc.2011.08.025 Brida, 2022, Heart failure in adults with congenital heart disease, Int. J. Cardiol., 357, 39, 10.1016/j.ijcard.2022.03.018 Lu, 2022, Heart failure and patient-reported outcomes in adults with congenital heart disease from 15 countries, J. Am. Heart Assoc., 11, 10.1161/JAHA.121.024993 Farr, 2022, Adult survivors of moderate and great complexity congenital heart disease undergoing general surgery procedures: how do they fare?, Am. J. Surg., 223, 841, 10.1016/j.amjsurg.2021.08.021 Parikh, 2019, Incidence of ESKD and mortality among children with congenital heart disease after cardiac surgery, Clin. J. Am. Soc. Nephrol., 14, 1450, 10.2215/CJN.00690119 Brock, 2019, Atrial fibrillation in adults with congenital heart disease following cardiac surgery in a single center: analysis of incidence and risk factors, Congenit. Heart Dis., 14, 924, 10.1111/chd.12857 Giri, 2017, Novel compound heterozygous ASXL3 mutation causing Bainbridge-ropers like syndrome and primary IGF1 deficiency, Int. J. Pediatr. Endocrinol., 2017, 8, 10.1186/s13633-017-0047-9 Duployez, 2016, Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21, Leuk. Lymphoma, 57, 199, 10.3109/10428194.2015.1037754 Wayhelova, 2019, Novel de novo frameshift variant in the ASXL3 gene in a child with microcephaly and global developmental delay, Mol. Med. Rep., 20, 505 Zhang, 2021, Alteration of long non-coding RNAs and mRNAs expression profiles by compound heterozygous ASXL3 mutations in the mouse brain, Bioengineered, 12, 6935, 10.1080/21655979.2021.1974811 Fu, 2021, Compound heterozygous mutation of the ASXL3 gene causes autosomal recessive congenital heart disease, Hum. Genet., 140, 333, 10.1007/s00439-020-02200-z Xu, 2022, Emerging role of LncRNAs in autoimmune, Lupus, Inflammation., 45, 937, 10.1007/s10753-021-01607-8 Kichi, 2022, The emerging role of EMT-related lncRNAs in therapy resistance and their applications as biomarkers, Curr. Med. Chem., 29, 4574, 10.2174/0929867329666220329203032 Nociti, 2021, What do we know about the role of lncRNAs in multiple sclerosis?, Neural Regen Res, 16, 1715, 10.4103/1673-5374.306061 Okuyan, 2022, LncRNAs in osteoarthritis, Clin. Chim. Acta, 532, 145, 10.1016/j.cca.2022.05.030 Ye, 2021, Potential therapeutic targeting of lncRNAs in cholesterol homeostasis, Front Cardiovasc Med, 8, 10.3389/fcvm.2021.688546 Shefler, 2022, Skin-expressing lncRNAs in inflammatory responses, Front. Genet., 13, 10.3389/fgene.2022.835740 Marguerie, 2006, Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice, Cardiovasc. Res., 71, 50, 10.1016/j.cardiores.2006.03.021 Huang, 2022, MicroRNA-338-3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression, J. Clin. Lab. Anal., 36, 10.1002/jcla.24584 Mundhofir, 2013, p.Ser252Trp and p.Pro253Arg mutations in FGFR2 gene causing Apert syndrome: the first clinical and molecular report of Indonesian patients, Singap. Med. J., 54, e72, 10.11622/smedj.2013055 Ali, 2020, Beyond the RNA-dependent function of LncRNA genes, Elife, 9, 10.7554/eLife.60583 Panni, 2020, Non-coding RNA regulatory networks, Biochim Biophys Acta Gene Regul Mech, 1863, 10.1016/j.bbagrm.2019.194417 Toni, 2020, Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failure, Am. J. Physiol. Heart Circ. Physiol., 318, H1308, 10.1152/ajpheart.00511.2019 Touma, 2016, Decoding the long noncoding RNA during cardiac maturation: a roadmap for functional discovery, Circ Cardiovasc Genet, 9, 395, 10.1161/CIRCGENETICS.115.001363 Kim, 2021, Spatiotemporal expression of long noncoding RNA Moshe modulates heart cell lineage commitment, RNA Biol., 18, 640, 10.1080/15476286.2021.1976549 Ma, 2021, Long non-coding RNA SAP30-2:1 is downregulated in congenital heart disease and regulates cell proliferation by targeting HAND2, Front. Med., 15, 91, 10.1007/s11684-020-0778-5 Lu, 2021, Knockdown of long noncoding RNA SNHG14 protects H9c2 cells against hypoxia-induced injury by modulating miR-25-3p/KLF4 Axis in vitro, J. Cardiovasc. Pharmacol., 77, 334, 10.1097/FJC.0000000000000965 Zhu, 2018, Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR-29c in chronic hypoxia, Mol. Med. Rep., 18, 3451